Phathom Pharmaceuticals Target Price

Where could PHAT trade next? Consensus target price: $21.

Get informed when a big investor buys or sells

+ Follow

Share Price

$8.57

Average Target Price

$21.33

148.9% upside

3 analysts in the last 4 months

High: $22 | Low: $20

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-31	Craig-HallumChase Knickerbocker	$20	133.4% upside
2026-07-31	Guggenheim	$22	156.7% upside
2026-07-30	Needham	$22	156.7% upside
2026-03-27	BarclaysJenna Davidner	$18	110% upside
2026-02-26	Stifel NicolausAnnabel Samimy	$28	226.7% upside
2025-12-11	Raymond JamesMartin Auster	$28	226.7% upside
2025-12-08	BarclaysJenna Davidner	$16	86.7% upside
2025-10-31	Craig-HallumChase Knickerbocker	$22	156.7% upside
2025-10-31	H.C. Wainwright	$26	203.4% upside
2025-10-30	GuggenheimYatin Suneja	$20	133.4% upside
2025-03-07	Guggenheim	$18	110% upside
2024-08-08	Goldman SachsPaul Choi	$12	40% upside
2024-07-19	H.C. WainwrightMatthew Caufield	$28	226.7% upside
2024-05-02	Stifel NicolausAnnabel Samimy	$24	180% upside
2024-01-05	NeedhamJoseph Stringer	$26	203.4% upside
2023-01-04	BMO Capital	$35	308.4% upside
2023-01-04	Needham	$25	191.7% upside
2022-11-14	BMO Capital	$38	343.4% upside
2022-11-11	Guggenheim	$30	250.1% upside

Phathom Pharmaceuticals (PHAT) FAQ

As of the most recent data, PHAT shows a target price of $21. Scroll down for historical charts and peer comparison views.

If Phathom Pharmaceuticals moved to the average analyst target of $21, shares would be roughly 148.9% higher than $8.57. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Phathom Pharmaceuticals's earnings trajectory.

Besides this target price page, Stockcircle has Phathom Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $21) with ownership activity and broader fundamentals.

Phathom Pharmaceuticals's target price is $21; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.